Furthermore, a key role of integrin αvβ3 as a cancer stem cell driver associated with resistance to EGFR inhibitors has been demonstrated in breast, lung, and pancreatic carcinomas [23]. This evidence concerns the gene EGFR and exocrine pancreatic carcinoma.